PGEN - Precigen - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

386M

Cash

44.76M

Avg Qtr Burn

-15.66M

Short % of Float

9.83%

Insider Ownership

11.49%

Institutional Own.

61.68%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PRGN-2009 OTS AdenoVerse™ +/- Pembrolizumab Details Cancer, Solid tumor/s, Squamous cancers	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRGN-2009 AdenoVerse™ + Pembrolizumab Details Cancer, Cervical cancer	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRGN-2012 AdenoVerse™ Details Recurrent respiratory papillomatosis, Cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRGN-3005 UltraCAR-T® Details Ovarian cancer, Cancer	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRGN-3006 UltraCAR-T® Details Cancer, Acute myeloid leukemia	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PRGN-3007 UltraCAR-T® Details Cancer, Blood cancer, Solid tumor/s	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AG019 ActoBiotics™ Details Type 1 diabetes, Diabetes	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.